MedTrace Logo

Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization

NCT03486262 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-10-11

No results posted yet for this study

Summary

Retrospective inclusion of lung cancers developed in a context of idiopathic pulmonary fibrosis, diagnosed and / or treated in participating centers. The cases are recovered retrospectively from the records of the pulmonology and pathology departments of our various partners.

Conditions

  • Lung Cancer and Idiopathic Pulmonary Fibrosis

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Auréie CAZES, MD PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03486262 on ClinicalTrials.gov